Katrina Thornber, Author at European Medical Journal - Page 23 of 54

Minimal Residual Disease May Predict NSCLC Recurrence After Osimertinib

Molecular residual disease detection may help identify patients with EGFR-mutated NSCLC who could benefit from prolonged adjuvant osimertinib

Deep-Learning Models Could Improve Hepatocellular Carcinoma Prognosis

Deep-learning (DL) radiopathomics models can help predict the presence of vessels encapsulating tumour clusters (VETC) in hepatocellular carcinoma.

At-Home Smell Test Detects Early Cognitive Decline in Alzheimer’s

A new study reveals how an at-home smell test can detect early cognitive decline, aiding Alzheimer’s screening.

The Role of Sleep Quality in Geriatric Type 2 Diabetes Management

Poor sleep quality in geriatric type 2 diabetes patients is linked to worse glycaemic control and complications.

Maternal Flu Vaccination: Reducing Risks for Newborns

Beyond antibody transfer through the placenta, breastfeeding may further enhance infant protection.

Researchers Identify the Key Genetic Driver of Lewy Body Disease Pathology

A new study reveals that APOE ε4 drives Lewy body severity, reshaping LBD genetic understanding.

EAU 2025 - Micro-Ultrasound Rivals MRI in Prostate Cancer Detection

Micro-ultrasound matches MRI in prostate cancer detection, offering faster, cheaper diagnosis.

EAU 2025 – Double TB Vaccine Shows Promise in Bladder Cancer Treatment

TB vaccine boosts immunity in bladder cancer patients, all cancer-free after 5 years.

Can Chitosan Improve Liver Function in NAFLD?

Chitosan, a dietary fibre derived from chitin in fungi, mushrooms, and crustaceans, has shown potential for weight and fat reduction.

Systemic Sclerosis Increases Risk of Lung, Gynaecological, and Blood Cancers

Patients with systemic sclerosis (SSc) face a higher risk of death from lung, gynecological cancers, and T/NK lineage lymphomas, according to a new study.